IP Library Granted Patent US 11,576,971
Granted Patent B2
US 11,576,971 · App. 17/350,299 · Granted Feb 14, 2023

Method of filling a container with no headspace

Inventors: John Ogez (Longmont, CO); Jun Liu (Pacifica, CA); Wenchang Ji (Oak Park, CA); Patrick Daniel Begley (San Jose, CA); Isaias Prado (Oxnard, CA); Mark Manning (Johnstown, CO)
Assignee: Coherus Biosciences, Inc.
A61K39/39591A61K9/08A61K47/183B65B3/003B65B7/2821B65B31/00C07K16/241A61J1/062A61K9/0019A61K47/02C07K2317/21C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,576,971
App. No.
17/350,299
Granted
Feb 14, 2023
Kind
B2
Abstract

The present invention is directed to methods for filling a container wherein the filled container has no headspace. The present invention is further directed to methods for stabilizing an aqueous drug substance solution by filling a container with the aqueous drug substance solution wherein the filled container has no headspace. The present invention is further directed to methods for detecting headspace in a container.

Claims (20)

1. A method for preparing a container with zero headspace comprising an aqueous solution, the method comprising:

a) providing a container with an open end;

b) providing a degassed aqueous solution that is free of a polyol, a sugar, and a surfactant;

c) filling the container via the open end with the degassed aqueous solution;

d) purging the container with carbon dioxide;

e) inserting a stopper into the open end of the container creating a headspace of carbon dioxide; and

f) storing the container at about less than 10° C. for at least about 18 hours,

wherein the stopper can move within the container while maintaining an airtight seal; and the storing step results in the container having zero headspace.

2. The method of claim 1 , wherein prior to the purging step or prior to inserting the stopper, the container is subjected to a vacuum.

3. The method of claim 2 , wherein the vacuum applies a pressure to the container of at least 27.5 inHg.

4. The method of claim 1 , wherein the step of purging the container with carbon dioxide comprises providing carbon dioxide to the container at a flow rate of about 10 milliliters/minute for 0.5 minutes.

5. The method of claim 1 , wherein the container is stored for at least about 2 days.

6. The method of claim 1 , wherein the container is stored at about less than 10° C. for at least about 3 days.

7. The method of claim 1 , wherein the container is stored at about less than 10° C. for at least about 4 days.

8. The method of claim 1 , wherein the container is stored at about 4° C.

9. The method of claim 1 , wherein the stopper is coated with silicone oil.

10. The method of claim 9 , wherein the stopper is coated with about 0.4 mg of silicone oil.

11. The method of claim 1 , wherein, following the storing step, the aqueous solution comprises less than about 6,000 subvisible particles having a size of ≥10 μm per 0.8 mL of the aqueous solution and less than about 600 subvisible particles having a size of ≥25 μm per 0.8 mL of the aqueous solution.

12. The method of claim 1 , wherein the container is a syringe or a cartridge.

13. The method of claim 1 , wherein the aqueous solution is further free or substantially free of a buffer, a salt, a stabilizer, or any combination thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2024
From: COHERUS BIOSCIENCES, INC.
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069084/0884 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 59436/0055 Recorded May 9, 2024
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
Reel/Frame 067378/0256 →
SECURITY INTEREST Recorded May 8, 2024
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.; SURFACE ONCOLOGY, LLC; COHERUS ONCOLOGY SUPPORTIVE CARE LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 067348/0160 →
SECURITY INTEREST Recorded Mar 18, 2022
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059436/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2021
From: OGEZ, JOHN; LIU, JUN; JI, WENCHANG; BEGLEY, PATRICK DANIEL; PRADO, ISAIAS; MANNING, MARK
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 056664/0564 →
Continuity (6)
Continuation 15492999 · Apr 20, 2017
Provisional Application 62453370 · Feb 1, 2017
Provisional Application 62440955 · Dec 30, 2016
Provisional Application 62438216 · Dec 22, 2016
Provisional Application 62325387 · Apr 20, 2016
Related Publication 20220040300A1 · Feb 10, 2022